Financhill
Back

Genpact Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
68

G
Genpact

Last Price:
$45.97
Seasonality Move:
1.47%
Buy
59

ITCI
Intra-Cellular Therapies

Last Price:
$127.16
Seasonality Move:
2.93%
Buy
68
Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $46.16. The Score for G is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • G is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $126.50. The Score for ITCI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $46.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and G is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $126.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.39 Buy
Relative Strength Index (14 RSI): 69.27 Buy
Chaikin Money Flow: -554899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.57 - 44.55) Buy
Bollinger Bands (100): (38.63 - 44.63) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.15 Buy
Relative Strength Index (14 RSI): 85.99 Buy
Chaikin Money Flow: -4610836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.77 - 112.85) Buy
Bollinger Bands (100): (70.61 - 95.53) Buy

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.47 Buy
20-day SMA: 43.53 Buy
50-day SMA: 44.41 Buy
200-day SMA: 37.36 Buy
8-day EMA: 44.69 Buy
20-day EMA: 44.09 Buy
50-day EMA: 43.36 Buy
200-day EMA: 39.4 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 117.15 Buy
20-day SMA: 97.24 Buy
50-day SMA: 90.5 Buy
200-day SMA: 77.48 Buy
8-day EMA: 117.53 Buy
20-day EMA: 103.78 Buy
50-day EMA: 92.89 Buy
200-day EMA: 79.55 Buy

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.31 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):